# PulseMagic™ TrueForce™ PAF NMPA Study

> **NCT07720557** · NA · NOT_YET_RECRUITING · sponsor: **Shanghai MicroPort EP MedTech Co., Ltd.** · enrollment: 150 (estimated)

## Conditions studied

- Atrial Fibrillation (AF)
- Paroxysmal AF
- Drug Refractory Paroxysmal Atrial Fibrillation
- Atrial Arrhythmia

## Interventions

- **DEVICE:** PFA Ablation catheter

## Key facts

- **NCT ID:** NCT07720557
- **Lead sponsor:** Shanghai MicroPort EP MedTech Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-07-10
- **Primary completion:** 2028-07-01
- **Final completion:** 2028-11-30
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2026-07-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07720557

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07720557, "PulseMagic™ TrueForce™ PAF NMPA Study". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07720557. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*